The race for an oral multiple sclerosis medication took one further step today, when Teva and Active Biotech announced that they were going to begin the final Phase of clinical testing for their pill candidate, called laquinimod.
This followed the successful conclusion of Phase II, as well as consultations with the US FDA. Drugmakers are cautious...
Story continues, please click "read more"...
The rest of this story is hosted at our sister site, Experience Project.com, absolutely free. Click the headline to see it:
MS Oral Drug Laquinimod Begins Phase III Trials
Experience Project is a community that connects people through shared experiences, not popularity or looks. Quickly find people who understand your life exactly, while reading through thousands of first-person stories about every life experience imaginable. We're really proud of it and would love your visit. Visit Experience Project today!
